These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

556 related items for PubMed ID: 33773605

  • 21. Newly onset cytopenias not always indicate a relapsing AML after allogeneic HSCT, a case of non-destructive post transplant lymphoproliferative disorder.
    Yiğit Kaya S, Askin AE, Bektas S, Çakır A, Gökmen Sevindik Ö.
    Leuk Res Rep; 2023; 19():100369. PubMed ID: 37213444
    [Abstract] [Full Text] [Related]

  • 22. [The diagnostic value of whole blood Epstein-Barr virus DNA load in lymphoproliferative diseases after allogeneic hematopoietic stem cell transplantation].
    Niu YY, Dong YJ, Yin Y, Xu WL, Liang ZY, Wang Q, Li Y, Liu W, Ou JP, Ren HY.
    Zhonghua Xue Ye Xue Za Zhi; 2021 Nov 14; 42(11):904-910. PubMed ID: 35045651
    [Abstract] [Full Text] [Related]

  • 23. Risk factors and clinical outcomes of Epstein-Barr virus DNAemia and post-transplant lymphoproliferative disorders after haploidentical and matched-sibling PBSCT in patients with hematologic malignancies.
    Gao XN, Lin J, Wang LJ, Li F, Li HH, Wang SH, Huang WR, Gao CJ, Yu L, Liu DH.
    Ann Hematol; 2019 Sep 14; 98(9):2163-2177. PubMed ID: 31243569
    [Abstract] [Full Text] [Related]

  • 24. Epstein-Barr virus-positive mucocutaneous ulcer arising in a post-hematopoietic cell transplant patient followed by polymorphic posttransplant lymphoproliferative disorder and cytomegalovirus colitis.
    Satou A, Kohno A, Fukuyama R, Elsayed AA, Nakamura S.
    Hum Pathol; 2017 Jan 14; 59():147-151. PubMed ID: 27569297
    [Abstract] [Full Text] [Related]

  • 25. The emergence of CD20-/CD19- tumor cells after rituximab therapy for Epstein-Barr virus-associated post-transplant lymphoproliferative disorder complicated with hemophagocytic lymphohistiocytosis.
    Yamamoto N, Nishimura N, Takeuchi M, Ito T, Yokozaki H, Hirase S, Kubokawa I, Mori T, Yanai T, Hayakawa A, Takeshima Y, Nishio H, Matsuo M, Imadome K, Iijima K.
    Eur J Pediatr; 2014 Dec 14; 173(12):1615-8. PubMed ID: 24169729
    [Abstract] [Full Text] [Related]

  • 26. Epstein-Barr Virus-Associated Post-Transplantation Lymphoproliferative Disease in Patients Who Received Anti-CD20 after Hematopoietic Stem Cell Transplantation.
    Pagliuca S, Bommier C, Michonneau D, Meignin V, Salmona M, Robin M, Prata PH, Xhaard A, de Fontbrune FS, Feghoul L, Dhedin N, de Latour RP, Caillat-Zucman S, Goff JL, Socié G.
    Biol Blood Marrow Transplant; 2019 Dec 14; 25(12):2490-2500. PubMed ID: 31421238
    [Abstract] [Full Text] [Related]

  • 27. Primary CNS post-transplant lymphoproliferative disorder following haploidentical HSCT using post-transplant high-dose cyclophosphamide.
    Toyosaki M, Onizuka M, Amaki J, Shiraiwa S, Aoyama Y, Machida S, Kawai H, Murayama H, Ogiya D, Matsui K, Kawakami S, Harada K, Kondo Y, Hirabayashi K, Nakamura N, Ogawa Y, Kawada H, Ando K.
    Blood Cell Ther; 2019 Feb 25; 2(1):1-4. PubMed ID: 37969696
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Epstein-Barr virus-associated pneumonia in patients with post-transplant lymphoproliferative disease after hematopoietic stem cell transplantation].
    Liu QF, Fan ZP, Luo XD, Zhang Y, Sun J.
    Zhonghua Yi Xue Za Zhi; 2008 Dec 02; 88(44):3123-6. PubMed ID: 19159594
    [Abstract] [Full Text] [Related]

  • 31. Epstein-Barr virus-associated post-transplant lymphoproliferative disease after bone marrow transplantation mimicking graft-versus-host disease.
    Claviez A, Tiemann M, Wagner HJ, Dreger P, Suttorp M.
    Pediatr Transplant; 2000 May 02; 4(2):151-5. PubMed ID: 11272609
    [Abstract] [Full Text] [Related]

  • 32. Role of Epstein-Barr virus status and immunophenotypic studies in the evaluation of exfoliative cytology specimens from patients with post-transplant lymphoproliferative disorders.
    Gibson SE, Picarsic J, Swerdlow SH, Pantanowitz L.
    Cancer Cytopathol; 2016 Jun 02; 124(6):425-35. PubMed ID: 26992116
    [Abstract] [Full Text] [Related]

  • 33. Risk factors evaluation of post-transplant lymphoproliferative disorders after allogeneic haematopoietic stem cell transplantation with comparison between paediatric and adult.
    Chen DB, Liu XY, Kong FZ, Jiang Q, Shen DH.
    J Clin Pathol; 2021 Nov 02; 74(11):697-703. PubMed ID: 34011618
    [Abstract] [Full Text] [Related]

  • 34. Survival outcomes of allogeneic hematopoietic cell transplants with EBV-positive or EBV-negative post-transplant lymphoproliferative disorder, A CIBMTR study.
    Naik S, Riches M, Hari P, Kim S, Chen M, Bachier C, Shaughnessy P, Hill J, Ljungman P, Battiwalla M, Chhabra S, Daly A, Storek J, Ustun C, Diaz MA, Cerny J, Beitinjaneh A, Yared J, Brown V, Page K, Dahi PB, Ganguly S, Seo S, Chao N, Freytes CO, Saad A, Savani BN, Woo Ahn K, Boeckh M, Heslop HE, Lazarus HM, Auletta JJ, Kamble RT.
    Transpl Infect Dis; 2019 Oct 02; 21(5):e13145. PubMed ID: 31301099
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases.
    Styczynski J, Einsele H, Gil L, Ljungman P.
    Transpl Infect Dis; 2009 Oct 02; 11(5):383-92. PubMed ID: 19558376
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction.
    Kinch A, Oberg G, Arvidson J, Falk KI, Linde A, Pauksens K.
    Scand J Infect Dis; 2007 Oct 02; 39(3):235-44. PubMed ID: 17366054
    [Abstract] [Full Text] [Related]

  • 39. The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation.
    Sundin M, Le Blanc K, Ringdén O, Barkholt L, Omazic B, Lergin C, Levitsky V, Remberger M.
    Haematologica; 2006 Aug 02; 91(8):1059-67. PubMed ID: 16885046
    [Abstract] [Full Text] [Related]

  • 40. Post-transplant lymphoproliferative disease in children, adolescents, and young adults.
    Gross TG, Rubinstein JD.
    Hematol Oncol; 2023 Jun 02; 41 Suppl 1():48-56. PubMed ID: 37294957
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.